{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:31:32Z","timestamp":1793637092616,"version":"4.5.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.japh.2021.11.012","type":"journal-article","created":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T01:26:52Z","timestamp":1636853212000},"page":"575-579.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Integration of clinical pharmacists into a heart failure clinic within a safety-net hospital"],"prefix":"10.1016","volume":"62","author":[{"given":"Shivani P.","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1517-5682","authenticated-orcid":false,"given":"Neal M.","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keana","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Entabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheba","family":"Meymandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadrine","family":"Balady-Bouziane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3127-8158","authenticated-orcid":false,"given":"Patrick","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.japh.2021.11.012_bib3","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.japh.2021.11.012_bib4","doi-asserted-by":"crossref","first-page":"e07","DOI":"10.15420\/usc.2020.29","article-title":"Optimizing guideline-directed medical therapies for heart failure with reduced ejection fraction during hospitalization","volume":"15","author":"Dixit","year":"2021","journal-title":"US Cardiol"},{"issue":"1","key":"10.1016\/j.japh.2021.11.012_bib5","first-page":"1","article-title":"Current perspectives on the role of the pharmacist in heart failure management","volume":"7","author":"Cheng","year":"2017","journal-title":"Integr Pharm Res Pract"},{"issue":"3","key":"10.1016\/j.japh.2021.11.012_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/MLR.0000000000000687","article-title":"Safety-net hospitals face more barriers yet use fewer strategies to reduce readmissions","volume":"55","author":"Figueroa","year":"2017","journal-title":"Med Care"},{"issue":"6","key":"10.1016\/j.japh.2021.11.012_bib7","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1161\/HYPERTENSIONAHA.115.06023","article-title":"Cost-effectiveness of a physician-pharmacist collaboration intervention to improve blood pressure control","volume":"66","author":"Polgreen","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.japh.2021.11.012_bib8","unstructured":"Disproportionate share hospital (DSH) program final eligibility list [PDF]. Dhcs. 2019. Available at: https:\/\/www.dhcs.ca.gov\/formsandpubs\/publications\/Documents\/DSH\/DSH-Eligibility-List-FY21-22.pdf. Accessed January 7, 2021."},{"issue":"11","key":"10.1016\/j.japh.2021.11.012_bib9","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/ejhf.838","article-title":"The mortality risk of deferring optimal medical therapy in heart failure: a systematic comparison against norms for surgical consent and patient information leaflets","volume":"19","author":"Zaman","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.japh.2021.11.012_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ahj.2007.03.030","article-title":"Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry","volume":"154","author":"Fonarow","year":"2007","journal-title":"Am Heart J"},{"issue":"10","key":"10.1016\/j.japh.2021.11.012_bib11","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/ejhf.900","article-title":"Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BioStat-CHF","volume":"19","author":"Ferreira","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.japh.2021.11.012_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/0310057X0803600109","article-title":"Pre-existing cardiac disease, troponin I elevation and mortality in patients with severe sepsis and septic shock","volume":"36","author":"Scott","year":"2008","journal-title":"Anaesth Intensive Care"},{"issue":"1","key":"10.1016\/j.japh.2021.11.012_bib14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1183\/09031936.00117312","article-title":"Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia","volume":"43","author":"Sibila","year":"2014","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.japh.2021.11.012_bib15","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.sapharm.2012.11.001","article-title":"Exploring the value of clinical pharmacy services for patients with diabetes in safety net settings","volume":"9","author":"Kauffman","year":"2013","journal-title":"Res Social Adm Pharm"},{"issue":"6","key":"10.1016\/j.japh.2021.11.012_bib16","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"issue":"10254","key":"10.1016\/j.japh.2021.11.012_bib17","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319121004738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319121004738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:48:58Z","timestamp":1761544138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319121004738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1544319121004738"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2021.11.012","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integration of clinical pharmacists into a heart failure clinic within a safety-net hospital","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2021.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}